Description
Linaglip-M 2.5/500 mg is a fixed-dose combination tablet designed to manage blood glucose levels in adults with type 2 diabetes mellitus. It combines two antihyperglycemic agents:
-
Linagliptin: A DPP-4 inhibitor that enhances the body's natural incretin hormones, increasing insulin release and decreasing glucagon levels in response to meals.
-
Metformin Hydrochloride: A biguanide that reduces hepatic glucose production, decreases intestinal glucose absorption, and improves insulin sensitivity.
Together, these agents work synergistically to provide effective glycemic control, addressing both fasting and postprandial blood sugar levels.
.webp)
 1000 MG.jpg)
.webp)
 4ML.jpg)
.jpeg)
.webp)
.jpeg)
Change Language